Home Blog Page 16

EQT agrees to acquire Cleanaway, a leading Australian integrated waste management and resource recovery platform

By
Advertorial Desk
-
  • EQT enters into definitive agreements to acquire 100% of the shares in Cleanaway through a scheme of arrangement for A$3.095 cash per share less the cash amount of any dividends (including any special dividend) or other distributions declared or paid1
  • The Cleanaway Board unanimously recommends shareholders vote in favor of the Scheme, in the absence of a superior proposal and subject to an Independent Expert concluding (and continuing to conclude) that the Scheme is in Cleanaway shareholders’ best interests
  • EQT looks to support Cleanaway’s next phase of development, drawing on its global waste management experience, Australian presence and long-term active ownership approach

ABU DHABI, UAE, Oct. 19, 2026 /PRNewswire/ — EQT is pleased to announce that EQT Infrastructure VI (“EQT”) has entered into a binding Scheme Implementation Deed with Cleanaway Waste Management Limited (ASX: CWY) (“Cleanaway” or the “Company”) to acquire 100 percent of Cleanaway’s issued ordinary shares by way of a scheme of arrangement (the “Scheme”).

Under the Scheme, Cleanaway shareholders will receive A$3.095 in cash for each Cleanaway share, subject to any applicable adjustment for further dividends or distributions (“Scheme Consideration”)2. The cash consideration implies an enterprise valuation of approximately A$9.3 billion3 and represents a premium of 32.1% to the last closing share price of Cleanaway of A$2.37 per share on 12 August 2026, the last full day of trading prior to the first media release from Cleanaway about a potential transaction.

The Cleanaway Board unanimously recommends that Cleanaway shareholders vote in favor of the Scheme, in the absence of a superior proposal and subject to an Independent Expert concluding, and continuing to conclude, that the Scheme is in the best interests of Cleanaway shareholders.

Cleanaway is a leading integrated waste management and resource recovery company in Australia, providing essential collection, recycling, treatment and disposal services to households, businesses, councils and communities across the country. Its integrated national infrastructure network, longstanding customer relationships and operating capabilities position Cleanaway to serve Australia’s growing need for safe, reliable waste management and more efficient resource recovery.

As one of the world’s most active investors in waste management and environmental services, EQT brings deep sector expertise and an established track record of supporting businesses across Asia Pacific, Europe and North America. EQT’s global waste and environmental services investments include Urbaser, ReWorld, Encyclis and Arcwood. EQT intends to partner with Cleanaway’s management team and employees to focus on long-term growth, operational excellence and supporting Australia’s circular economy. 

Sam Franklin, Managing Director, at EQT Infrastructure, said: “Cleanaway has built an exceptional national platform providing services to Australians every day. We see significant opportunity to build on these strong foundations by investing in the infrastructure needed to meet Australia’s evolving waste management and resource recovery needs, and to support Cleanway’s management team as they enhance the performance of its integrated network and strengthen outcomes for customers and communities.”

Tobias Küng, Partner at EQT Infrastructure, said: “We look forward to partnering with Cleanaway’s management team, combining their deep local expertise with EQT’s global experience in waste and environmental services and disciplined, long-term investment approach to support the company’s next chapter of growth.”

Cleanaway Chair, Samantha Hogg, said: “The Board has carefully assessed EQT’s proposal against the value of Cleanaway on a standalone basis, including the opportunities ahead of us under Blueprint 2030 2.0 and the investment and execution required to deliver them. Following a disciplined process and engagement with EQT, the Board is unanimous in its view that the Scheme delivers strong and certain cash value to shareholders, at a significant premium to Cleanaway’s undisturbed share price. Accordingly, the Board unanimously recommends that shareholders vote in favour of the Scheme, in the absence of a Superior Proposal and subject to the Independent Expert concluding (and continuing to conclude) that the Scheme is in the best interests of Cleanaway shareholders.”

The Scheme is subject to approval by Cleanaway shareholders and the Federal Court of Australia, receipt of required regulatory approvals and other conditions set out in the Scheme Implementation Deed. Subject to satisfaction or waiver of those conditions, where permitted, the transaction is expected to be implemented by the end of March 2027. Further details are contained in Cleanaway’s ASX announcement published today.

Cleanaway shareholders are not required to take any action at this stage. A scheme booklet, including an Independent Expert’s report and information about the Scheme meeting, is expected to be provided to shareholders in due course.

With this transaction, EQT Infrastructure VI is expected to be 85-90 percent invested, including closed and signed investments and less any anticipated syndication.

J.P. Morgan and RBC Capital Markets acted as joint financial advisors to EQT and Allens acted as legal advisor to EQT.

1 Plus any ticking fee, which applies where the implementation date is after 31 May 2027 and is an additional cash amount equal to $0.0002 per day, accruing daily for each day that has elapsed from (and including) 1 June 2027 to (and including) the implementation date.

2 Plus any ticking fee, which applies where the implementation date is after 31 May 2027 and is an additional cash amount equal to $0.0002 per day, accruing daily for each day that has elapsed from (and including) 1 June 2027 to (and including) the implementation date.

3 On a fully diluted basis, assuming 2,255.1 million fully paid ordinary shares and performance rights outstanding, total net debt and debt-like items ($2,288.7 million) and non-controlling interests ($1.6 million) as disclosed at June 2026 and FY26 underlying EBIT of $470.2 million.

Contact:
EQT Press Office, press@eqtpartners.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/eqt-agrees-to-acquire-cleanaway–a-leading-australian-integrated-waste-management-and-resource-recov,c4410303

The following files are available for download:

https://mb.cision.com/Main/87/4410303/4323671.pdf

261019 EQT agrees to acquire Cleanaway, a leading Australian integrated waste management and resource recovery platform

https://news.cision.com/eqt/i/cleanaway,c3573023

Cleanaway

 

Telix and Ekalia to Collaborate on Astatine-211 Production in the U.S.

By
Advertorial Desk
-
  • Collaboration establishes a framework for a dedicated U.S. source of astatine-211 (211At), a scarce, next-generation alpha-emitting isotope with significant potential in targeted alpha therapy (TAT).
  • Secures long-term, priority isotope access for Telix’s alpha therapy pipeline, including its TLX102-Tx candidate for glioblastoma and leptomeningeal disease, while also supporting third-party academic and industry programs.
  • First IBA alpha-beam cyclotron to be installed and operated at Telix’s RLS Radiopharmacies site near Philadelphia, PA.
  • Leverages Telix’s vertically integrated U.S. manufacturing and distribution platform, with a framework providing for the parties to evaluate additional installations at RLS sites as demand for 211At develops.

MELBOURNE, Australia and LOUVAIN-LA-NEUVE, Belgium and INDIANAPOLIS, Oct. 19, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) and Ekalia, a joint venture between IBA (Ion Beam Applications S.A., EURONEXT) and Framatome, today announced a collaboration to advance scalable United States (U.S.) production of astatine-211 (211At), an alpha-emitting radioisotope being investigated for targeted alpha therapy.

The collaboration brings together IBA’s specialized alpha-beam cyclotron technology, Framatome’s nuclear and isotope production expertise, and Telix’s U.S. radiopharmacy and “last-mile” infrastructure, clinical portfolio and radiopharmaceutical development capabilities. The alliance expands into the U.S. the strategic partnership formed by IBA and Framatome in Europe to advance industrial-scale ²¹¹At production. The first installation at RLS Trevose is intended to establish a reproducible production model, with the potential for further rollout across the RLS network as demand develops.

Astatine-211 is recognized as a promising alpha-emitting radioisotope for the development of innovative cancer treatments[1]. However, its broader adoption remains constrained by the availability of sufficient production capacity[2]. The collaboration is intended to improve robust, reliable, and timely access to 211At for research and clinical development through a network of production sites in close proximity to clinical centers, helping to further establish theranostics as a cornerstone of precision oncology.

For Telix, the collaboration is expected to support the development of several early-stage therapeutic candidates, including TLX102-Tx (211At astato-L-phenylalanine), a TAT being evaluated for glioblastoma and leptomeningeal disease, as well as future 211At programs. The collaboration is also intended to provide production capacity for third-party academic and industry programs, helping to expand the U.S. 211At development ecosystem.

Bruno Scutnaire, CEO of Ekalia (company in formation) said: “IBA’s specialized alpha-beam cyclotron technology is designed to enable reliable astatine-211 production at the point of need. Building on our work with Framatome in Europe, Telix’s U.S. infrastructure enables us to move faster towards establishing our first U.S. production unit, while laying the foundations for Ekalia’s broader development in the country.”

Chad Watkins, General Manager, Isotope Strategy at Telix, continued: “Owning the path from isotope to patient is central to our development and commercialization strategy. This collaboration gives Telix a dedicated, long-term source of astatine-211 to advance our alpha therapy pipeline, and demonstrates the strategic value of the RLS platform as a host for next-generation isotope production in the U.S. We are delighted to partner with IBA and Framatome, two global leaders in this field, to help advance reliable, scalable astatine-211 production.”

About EKALIA

Ekalia (company in formation) is the joint venture between IBA (Ion Beam Applications, EURONEXT) and Framatome, dedicated to deploying an international network of industrial-scale Astatine-211 production sites close to customers, making this promising radioisotope available for future targeted cancer therapies. Jointly owned by the two partners, the new company combines IBA’s cutting edge cyclotron and isotope production technologies with Framatome’s nuclear industrial expertise. Together, the two companies intend to establish a network of production sites across Europe and North America.

About Telix Pharmaceuticals Limited

Telix Pharmaceuticals (ASX: TLX, NASDAQ: TLX) is a commercial-stage global radiopharmaceutical company advancing targeted theranostics to improve outcomes for people with cancer across the patient journey. Theranostics pairs a precision diagnostic with a targeted therapy to both diagnose and treat disease.

Telix’s commercial franchise is anchored by its precision diagnostics portfolio: Illuccix® (kit for the preparation of gallium-68 gozetotide injection), commercially available in 22 countries, including the U.S.; Gozellix® (kit for the preparation of gallium-68 gozetotide injection), approved by the U.S. Food and Drug Administration (FDA) for prostate imaging; and Pixclara® (floretyrosine F 18), approved by the FDA for glioma imaging. The Company’s late-stage therapeutic pipeline includes three investigational assets in pivotal-stage trials: TLX591-Tx (lutetium-177 (177Lu) rosopatamab tetraxetan) in prostate cancer, TLX101-Tx (iodofalan 131I) in recurrent glioblastoma, and TLX250-Tx (lutetium (177Lu) girentuximab tetraxetan) in kidney cancer. These are complemented by a deep pipeline of next-generation candidates including TLX102-Tx (211At astato-L-phenylalanine), a 211At labelled TAT candidate being evaluated for glioblastoma and leptomeningeal disease.

Telix is headquartered in Melbourne, Australia, with operations across North America, Europe, Latin America, and Asia-Pacific. For more information, visit www.telixpharma.com or follow Telix on LinkedIn, X, and Facebook.

Investor Relations

Media 

Annie Kasparian

annie.kasparian@telixpharma.com

Eliza Schleifstein

917.763.8106 (Mobile)

Eliza@schleifsteinpr.com

 

Charlene Jaw                        

charlene.jaw@telixpharma.com

Legal Notices

Cautionary Statement Regarding Forward-Looking Statements. 
 

You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our Annual Report on Form 20-F filed with the SEC, or on our website.

The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification.  To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement.

This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “outlook”, “forecast” and “guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress, completion and results of Telix’s preclinical and clinical trials, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enroll and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix’s product candidates, manufacturing activities and product marketing activities; Telix’s ability to operationalize and derive value from collaborations, partnerships and similar arrangements; Telix’s sales, marketing and distribution and manufacturing capabilities and strategies; the commercialization of Telix’s product candidates, if or when they have been approved; Telix’s ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; the anticipated impact of U.S. and foreign tariffs and other macroeconomic conditions on Telix’s business, including as a result of war or other geopolitical conflicts; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements.

Trademarks and Trade Names. All trademarks and trade names referenced in this press release are the property of Telix Pharmaceuticals Limited (Telix) or, where applicable, the property of their respective owners. For convenience, trademarks and trade names may appear without the ® or ™ symbols. Such omissions are not intended to indicate any waiver of rights by Telix or the respective owners. Trademark registration status may vary from country to country. Telix does not intend the use or display of any third-party trademarks or trade names to imply any affiliation with, endorsement by, or sponsorship from those third parties.

©2026 Telix Pharmaceuticals Limited. All rights reserved.

[1] Lindegren et al. EJNMMI Radioph. and Chem. (2026) 11, 15 doi:10.1186/s41181-026-00428-0
[2] Albertsson P et al; Frontiers in Med (2023),9, 1076210: doi:10.3389/fmed.2022.1076210. 

SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES

By
Advertorial Desk
-

$90 million financing committed by Spice Expeditions, WashU and Moore and $50 million of bond proceeds to fund the scaling of profitable lending and launches of new products

MANILA, Philippines, Oct. 19, 2026 /PRNewswire/ — Salmon Group, a technology-driven banking and lending platform in the Philippines, today announces that it secured additional $140 million of financing to continue its growth in the Philippines.

Salmon co-founders (from left to right: George Chesakov, Pavel Fedorov and Raffy Montemayor) in front of Nasdaq's headquarters in Times Square, New York.
Salmon co-founders (from left to right: George Chesakov, Pavel Fedorov and Raffy Montemayor) in front of Nasdaq’s headquarters in Times Square, New York.

Proceeds from the financing round will fund the scaling of profitable lending (Salmon Credit Line and in-store lending) and nationwide roll-out of new products, including motorcycle and MSME lending.

In less than four years of operations, Salmon has become one of the fastest-growing technology companies in the Philippines, operating through a BSP-licensed bank, Salmon Bank (Rural Bank) and an SEC-licensed financing company, Salmon Finance.  

Today, the companies in Salmon Group serve millions of Filipinos through its Salmon app – one of the highest rated financial services apps in the Philippines with 9 million downloads, 4.8 rating on App Store and Google Play, 99.9% uptime, and dedicated 24/7 customer support.  Through the AI-powered credit engine of Salmon Finance, the group’s financing arm, Salmon is able to serve customers with limited credit history and provide credit decisions within minutes.

“Everyday financial services come with unnecessary friction for many Filipinos.  We’re removing these barriers and building innovative products with the reliability and security customers expect in today’s world,” said Pavel Fedorov, co-founder of Salmon. “We are doubling down on the opportunity in the Philippines as we believe deeply in its scale and in the importance of focus to deliver a differentiated execution.  This financing lets us do more: extend banking and credit access to more Filipinos, roll out new products, and keep raising the bar for the financial services industry in the country. We are grateful to our existing investors for backing the next stage of our mission.”

ABOUT SALMON

Salmon Group is a technology-driven financial services holding company building a banking and lending platform across Southeast Asia, starting with the Philippines. The Group operates a BSP-licensed bank, Salmon Bank (Rural Bank) Inc.; an SEC-licensed financing company, Salmon Finance Inc.; and a growing suite of financial products – all delivered through the Salmon app, a modern money app built for everyday Filipinos. Founded in July 2022 by banking and technology veterans Pavel Fedorov, George Chesakov, and Raffy Montemayor, Salmon is backed by leading US venture investors, IFC (World Bank Group), ADQ/Lunate, Antler as well as prominent Filipino investors. The Salmon app is rated 4.8 in both the App Store and Google Play, one of the highest ratings for a financial services app in the Philippines.

 

Solomon Credit Management and SACH Plan Joint Venture to Expand Healthcare and Wellness Brands Across Southeast Asia

By
Advertorial Desk
-

SINGAPORE – Media OutReach Newswire – 19 October 2026 – Solomon Credit Management (“Solomon”) and SACH Pte Ltd (“SACH”) today announced plans to establish a joint venture to identify, secure distribution rights for and distribute consumer brands across the wellness, medical technology, health technology and lifestyle industries. BUZUD, a Singapore-based healthcare technology company, has appointed SACH as an authorised distributor in Singapore, with Solomon expected to join the distributorship.

The partnership aims to connect healthcare brands with consumers seeking everyday tools to monitor and manage their health. In Singapore, 21.4% of citizens were aged 65 and above in June 2026, underscoring the need for accessible health and wellness solutions. The global wellness economy reached US$6.8 trillion in 2024 and is projected to approach US$9.8 trillion by 2029.

SACH brings experience in technology, e-commerce, retail, consumer engagement and live events, helping brands reach consumers through online and offline channels. Solomon, an independent business financing firm, will serve as Capital Partner, contributing capital and commercial and financial expertise to support distribution and expansion.

The companies intend to develop the partnership in stages: Solomon first supports SACH’s distribution of BUZUD as Capital Partner, then joins the distributorship, before both parties establish a dedicated business unit to secure distribution rights and distribute brands across multiple territories. Key terms and responsibilities are being finalised.

BUZUD focuses on accessible healthcare through medical devices and digital health technologies. It has a research collaboration with Tan Tock Seng Hospital to develop AI-supported diabetes management solutions combining carbohydrate estimation with continuous glucose monitoring. BUZUD also operates retail outlets at Raffles Hospital and Novena Square 2, alongside a retail partnership with Guardian Singapore.

Distribution will begin in Singapore, with expansion into other Southeast Asian markets as rights are secured, through e-commerce, retail, live events and partnerships with businesses, hospitals and research bodies.

“We strongly believe capital should do more than support business growth — it should create opportunities and meaningful impact. Our partnership with SACH represents a strategic step into the fast-growing healthcare and wellness sector, where we see tremendous long-term potential. By combining our financial expertise with SACH’s distribution capabilities, we aim to help promising brands like BUZUD expand their reach, scale sustainably and bring innovative healthcare solutions closer to the people who need them,” said Liong Qin Kai, Partner, Solomon Credit Management.

“Great healthcare products only create impact when they reach the people who need them. Our partnership with Solomon marks an important step for SACH into the healthcare and wellness sector, combining their financial strength with our distribution and consumer engagement capabilities. BUZUD is the first of many brands we hope to bring to market, helping them expand their reach, build lasting relationships with customers and make innovative healthcare solutions more accessible across Southeast Asia,” said Jonathan Zhang, CEO, SACH.

The partners are targeting completion of the proposed arrangement in December 2026, with further details to be announced once terms are finalised.
Hashtag: #SACH

The issuer is solely responsible for the content of this announcement.

About Solomon Credit Management

Solomon Credit Management is an independent business financing firm lending its own capital to small and medium-sized companies and larger corporates. Its financing approach is grounded in disciplined credit assessment and a clear understanding of each borrower’s business, cash flows and assets.

About SACH

SACH develops products and services across technology, e-commerce, retail, consumer engagement and live events.

Via Appia Tagaytay Named Emerging Hotel in Asia at the ACES Awards 2026

By
Advertorial Desk
-

TAGAYTAY, PHILIPPINES – Media OutReach Newswire – 19 October 2026 – Via Appia Tagaytay has been recognized as the Emerging Hotel in Asia 2026 at the prestigious ACES Awards, marking a significant milestone for the Italian-inspired boutique hotel and its growing presence in the region’s hospitality landscape.

Via Appia Tagaytay Hotel was recognised among Emerging Hotels in Asia at ACES Awards 2026 for its distinctive hospitality experience.
Via Appia Tagaytay Hotel was recognised among Emerging Hotels in Asia at ACES Awards 2026 for its distinctive hospitality experience.

The recognition celebrates Via Appia Tagaytay’s distinctive approach to boutique hospitality, bringing together Italian-inspired design, personalized VIP service, meaningful celebrations, and digital innovation to create guest experiences that are elegant, intimate, and memorable.
Inspired by the historic Via Appia Antica, one of ancient Rome’s oldest and most iconic roads, the hotel takes its name from a timeless symbol of journey, connection, and enduring elegance. At Via Appia Tagaytay, that spirit is reimagined as an invitation to pause, connect, celebrate, and create meaningful stories.
At the heart of the property is the question “Quo Vadis?” — Where are you going? For Via Appia, the answer is toward experiences worth remembering.
Whether the journey leads to a wedding, anniversary, romantic escape, family celebration, corporate retreat, or simply a much-needed pause, Via Appia Tagaytay is designed to transform each stay into something personal.
An Italian-Inspired Escape in Tagaytay
Positioned as an Italian Boutique Hotel, Via Appia Tagaytay brings the atmosphere of an Italian escape to one of the Philippines’ most beloved leisure destinations.
The property features 51 rooms, Italian-inspired architecture and landscaped surroundings, intimate spaces, wedding and event venues, an indoor pool, wellness facilities, and a replica of the Domine Quo Vadis Chapel. Its experiences range from Tuscan-inspired weddings and romantic dinners to personalized stays, wellness escapes, family gatherings, and intimate celebrations.
Rather than focusing solely on accommodation, Via Appia Tagaytay is building its identity around experiences designed to be difficult to replicate.
Where Italian Elegance Meets Filipino Hospitality
Via Appia Tagaytay believes that true luxury is not simply about scale or extravagance, it is about being remembered.
Through services such as VIP Butler Service, personalized welcome cards, birthday and anniversary surprises, and a dedicated Event Concierge, the hotel seeks to treat every guest as an individual rather than a room number.
This philosophy is captured in its brand promise: “Experience Italy in the Heart of Tagaytay.” The goal is to combine the charm of an Italian-inspired escape with the warmth, attentiveness, and genuine hospitality that define the Filipino experience.
Hospitality Designed for the Digital Traveler
While rooted in history, Via Appia Tagaytay is equally focused on the future. Its digital guest experience incorporates Digital Check-in, Express Checkout, QR Menus, WhatsApp and Viber Concierge, Digital Butler services, online room selection, electronic registration, mobile payment, and guest messaging.
For Via Appia, technology is not intended to replace hospitality, but to enhance it, giving guests greater convenience while preserving highly personalized service.
A Destination for Love, Celebration and Connection
The property is also developing its position as a destination for life’s most meaningful occasions, from Tuscan-inspired garden weddings, intimate and micro weddings, sunset celebrations,
Catholic weddings, and destination weddings to proposals, anniversaries, honeymoons, babymoons, engagements, and romantic dinners.
It also welcomes families, corporate groups, faith-based organizations, and retreat participants, creating a versatile destination for both intimate milestones and meaningful gatherings.
The ACES 2026 recognition affirms Via Appia Tagaytay’s vision of becoming one of Tagaytay’s preferred boutique destinations for romance, weddings, celebrations, family stays, corporate retreats, and personalized VIP hospitality.
For Via Appia Tagaytay, the journey is only beginning. Quo Vadis? Where are you going? Toward a place where every arrival has a story, every celebration has a setting, and every stay becomes a memory worth taking home.

The issuer is solely responsible for the content of this announcement.

Via Appia Tagaytay

Via Appia Tagaytay is an Italian-inspired boutique hotel in Tagaytay, Philippines, inspired by the historic Via Appia Antica of ancient Rome. The property combines Italian-inspired architecture and ambiance with personalized VIP hospitality, digital guest experiences, accommodations, wellness offerings, dining, wedding and event venues, and spaces for romantic escapes, family staycations, corporate retreats, and meaningful celebrations.
Brand Promise: Experience Italy in the Heart of Tagaytay.
Core Message: Stay. Celebrate. Fall in Love.

Questex’s IHIF Asia Connects Hospitality Leaders with Investors Managing $450B in AUM

By
Advertorial Desk
-

HONG KONG, Oct. 19, 2026 /PRNewswire/ — Questex’s IHIF Asia united leaders spanning hospitality, investment and real estate to explore market trends, economic factors and opportunities. It attracted 470+ delegates from 38 countries, a testament to its international reach. 46% of attendees were from investor, capital and ownership-related organisations representing $450B in AUM, 60% were first-time attendees.

Senior hospitality executives share insights on investment, growth and market opportunities at IHIF Asia 2026 in Hong Kong.
Senior hospitality executives share insights on investment, growth and market opportunities at IHIF Asia 2026 in Hong Kong.

“IHIF Asia demonstrated the strength of hospitality investment across the region, uniting the capital and leadership shaping the future. It reinforced its position as the premier platform for hospitality investment in Asia-Pacific,” said IB Saravanan, VP, Questex Asia.

The programme delivered thought leadership through panel discussions, fireside chats, presentations and networking. 125 speakers from 21 countries shared perspectives on investment, ownership, development, operations and policy.

The CEO panel united leaders from Minor Hotels, Pan Pacific Hotels Group, Hyatt Hotels and Resorts and Seibu Prince Hotels Worldwide Inc. who discussed competitive advantages, unlocking new value streams and building future-ready organizations.

Hospitality has emerged as a real estate asset class for family office capital. Reflecting on this investment, IHIF Asia featured content and networking for family offices and family office-owned property groups, supporting engagement and connections across this investor segment. The dedicated programme united 30+ family offices and family office-owned property groups.

Two new tracks focused on the region’s areas of growth. The BxR Asia – Brand x Residential track examined the intersection of hospitality brands and residential real estate. The Nippon Track examined the opportunities within its domestic hospitality market and the growing role of Japanese capital. It attracted 160 attendees and 20 speakers across four hours of focused programming.

Government and tourism organisations reinforced IHIF Asia’s role in connecting public and private sector stakeholders to advance hospitality investment and destination development including Singapore Tourism Board, Hong Kong Tourism Board, Tourism Western Australia, Oman, Turismo de Portugal, Brunei Investment Agency and Marjan. UN Tourism provided a global perspective on tourism growth, capital flows and investment opportunities.

IHIF Asia Digital lets you watch coverage of main stage sessions, extending the event’s reach to the broader hospitality investment community.

IHIF Asia 2027 takes place 8-10 September in Hong Kong.

Media Contact
Meryl Franzman
mfranzman@questex.com          

CCTV+: A Civilizational Dialogue Across 5000 Years — Liangzhu and the Origins of World Civilization, a China‑Russia Co‑produced Documentary, Premieres Globally

By
Advertorial Desk
-

BEIJING, Oct. 19, 2026 /PRNewswire/ — On October 18, 2026, the 4th Liangzhu Forum opened in Liangzhu, the sacred site that bears testimony to China’s 5,000‑year‑old civilization. On the same day, Liangzhu and the Origins of World Civilization, a documentary co-produced by Zhejiang Media Group Overseas Center (International Channel) and Russian Digital Television’s “My Planet” Channel, made its global debut. The film launches a cross‑millennia civilizational dialogue through visuals. It airs simultaneously on Zhejiang Media Group Overseas Center (International Channel), its English platform, Russia’s “My Planet” Channel, major global media outlets and the China Blue International Media Matrix.


CCTV+: A Civilizational Dialogue Across 5000 Years — Liangzhu and the Origins of World Civilization, a China‑Russia Co‑produced Documentary, Premieres Globally

In December 2025, during the 6th China‑Russia Media Forum in Beijing, the two sides signed a media cooperation agreement for long‑term collaboration in co‑production, promotion and cultural exchanges. This documentary stands as a signature achievement under this cooperation framework.

Shooting for the film began in Hangzhou last April. The joint Sino‑Russian crew visited iconic cultural sites including the Liangzhu Museum, the Archaeological Ruins of Liangzhu Ancient City, and the Grand Canal (Hangzhou Section). Combining on‑site cinematography, expert interviews, and archaeological footage, the film captures exquisite jade artifacts from the Fanshan Royal Cemetery, the grand Mojiaoshan palace foundations and the ancient water‑conservancy systems, showcasing Liangzhu’s city layout, jade craftsmanship, water‑management wisdom and rice‑farming culture.

Adopting two‑way perspectives, the film gathers insights from Chinese and Russian scholars including museum directors and young Sinologists. It helps Russian audiences understand China’s millennia‑long civilization from their own cultural context, and lets the world perceive the profound heritage of Chinese civilization.

As an innovative practice for international cultural communication, this production boosts Liangzhu’s global recognition and serves as a vivid footnote for people‑to‑people exchanges in the new era.

UTCC Wins Three Prestigious Awards from ACES Awards 2026

By
Advertorial Desk
-

University of the Thai Chamber of Commerce received three distinguished awards for educational excellence, national contribution, and leadership.


BANGKOK, THAILAND – Media OutReach Newswire – 19 October 2026 – University of the Thai Chamber of Commerce (UTCC) has been conferred awards in three categories at the ACES (Asia Corporate Excellence & Sustainability) Awards 2026: Premier Educational Institutions in Asia, Nation Builder Award, and Outstanding Leaders in Asia, the last of which was granted to President, Assoc. Prof. Thanavath Phonvichai, Ph.D. The awards will be presented at the ACES awarding ceremony on 15–16 October 2026 at the Mandarin Oriental, Kuala Lumpur, Malaysia.

Assoc. Prof. Thanavath Phonvichai, Ph.D., President of the University of the Thai Chamber of Commerce (UTCC), Outstanding Leaders in Asia at the ACES Awards 2026 in Kuala Lumpur, Malaysia.
Assoc. Prof. Thanavath Phonvichai, Ph.D., President of the University of the Thai Chamber of Commerce (UTCC), Outstanding Leaders in Asia at the ACES Awards 2026 in Kuala Lumpur, Malaysia.

The awards affirm UTCC’s position as a top private university in ASEAN and the best private university in Thailand. UTCC welcomes students from around the globe to study in Thailand, integrating academic learning with real-world business practice. Located in the heart of Bangkok, the campus places students at the center of Thailand’s economic activity, providing valuable exposure to industry leaders, businesses, and professional opportunities.

Operating under its “AI University, Practice University, Happy University, and International University” framework, UTCC has the highest rate of Google-certified faculty in Generative AI in Thailand and has maintained the Apple Distinguished School status for 15 consecutive years. With 92% of graduates employed within a year, the university pairs digital capability with strong career outcomes and ranks among Thailand’s most internationally diverse campuses.

Under the leadership of Assoc. Prof. Thanavath Phonvichai, Ph.D., UTCC has reached its highest student enrollment in 19 years and its strongest financial performance in over 6 decades. As the founder of the university’s Center for Economic and Business Forecasting (CEBF), he is among Thailand’s most widely cited voices on the economy.

The Nation Builder Award recognizes UTCC’s contribution to national development focusing on the RIECE Thailand, a peer-reviewed early-childhood programme supporting rural communities.

“These honours belong to our students, faculty, and the wider Thai Chamber of Commerce community,” said Assoc. Prof. Thanavath Phonvichai, Ph.D., President of UTCC. “They affirm our belief that combining academic excellence with hands-on practice can prepare future-ready graduates while helping to build a stronger nation.”
Hashtag: #UTCC #ACESAward

The issuer is solely responsible for the content of this announcement.

University of the Thai Chamber of Commerce

Founded in 1963 by the Thai Chamber of Commerce, University of the Thai Chamber of Commerce (UTCC) is a private university in Bangkok, Thailand, connecting education directly to the real economy. Backed by its AI-First approach, extensive industry partnerships, and the 263,785-member Thai Chamber of Commerce network, UTCC prepares entrepreneurial graduates ready for a fast-changing economy in Thailand and across the region.

1...151617...6,651Page 16 of 6,651